Comparison of the efficacy and safety of 2 oral doses of rimonabant versus placebo [Sanofi]

Myra Muramoto, MD, MPH

The study is a double blind, randomized, placebo-controlled parallel-group fixed dose clinical trial to evaluate the safety and efficacy of rimonabant for smoking cessation and maintenance in adults.

Location http://www.fcm.arizona.edu/index.cfm/1,108,323,0,html